Roche’s Atezolizumab injection (Tecentriq) approved for subcutaneous use in India. • Approval requires Roche to conduct a Phase IV clinical trial. • Subcutaneou
Browsing: Regulatory & Approvals
Regulatory updates, drug approvals, submissions, and compliance developments from authorities like FDA, EMA, and others.
FDA launches a program to streamline the construction of drug manufacturing sites in the U.S., enhancing domestic production capabilities.